REPLIGEN CORP Quarterly Income Tax Expense (Benefit) in USD from Q4 2011 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Repligen Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q4 2011 to Q4 2024.
  • Repligen Corp Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was -$4.74M, a 126% decline year-over-year.
  • Repligen Corp Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was -$1.52M, a 107% decline year-over-year.
  • Repligen Corp annual Income Tax Expense (Benefit) for 2024 was -$1.52M, a 107% decline from 2023.
  • Repligen Corp annual Income Tax Expense (Benefit) for 2023 was $21.1M, a 36.4% decline from 2022.
  • Repligen Corp annual Income Tax Expense (Benefit) for 2022 was $33.2M, a 31.4% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$1.52M -$4.74M -$23.1M -126% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-14
Q3 2024 $21.5M -$495K +$5.05M +91.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-18
Q2 2024 $16.5M $3.31M -$1.81M -35.3% Apr 1, 2024 Jun 30, 2024 10-Q/A 2024-11-18
Q1 2024 $18.3M $399K -$2.82M -87.6% Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-11-18
Q4 2023 $21.1M $18.3M +$14.1M +330% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-14
Q3 2023 $7.05M -$5.54M -$12.6M -178% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-18
Q2 2023 $19.7M $5.12M -$4.78M -48.3% Apr 1, 2023 Jun 30, 2023 10-Q/A 2024-11-18
Q1 2023 $24.4M $3.22M -$8.75M -73.1% Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-11-18
Q4 2022 $33.2M $4.26M -$1.48M -25.8% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-14
Q3 2022 $34.7M $7.06M -$672K -8.69% Jul 1, 2022 Sep 30, 2022 10-Q/A 2024-11-18
Q2 2022 $35.3M $9.9M +$1.77M +21.8% Apr 1, 2022 Jun 30, 2022 10-Q/A 2024-11-18
Q1 2022 $33.6M $12M +$8.31M +227% Jan 1, 2022 Mar 31, 2022 10-Q/A 2024-11-18
Q4 2021 $25.3M $5.74M +$10.7M Oct 1, 2021 Dec 31, 2021 10-K/A 2024-11-18
Q3 2021 $14.6M $7.73M +$4.54M +142% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $10.1M $8.13M +$7.97M +5010% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $2.09M $3.66M +$2.79M +325% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-27
Q4 2020 -$709K -$4.92M -$5.66M -764% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-22
Q3 2020 $4.95M $3.19M +$3.18M +26492% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 $1.77M $159K -$1.37M -89.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-27
Q1 2020 $3.14M $861K -$1.6M -65% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $4.74M $741K -$492K -39.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-17
Q3 2019 $5.23M $12K -$1.82M -99.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $7.05M $1.52M +$895K +142% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 $6.15M $2.46M +$1.34M +118% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $4.82M $1.23M +$11.9M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 -$7.04M $1.83M +$8.52M Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 -$15.6M $629K +$5.41M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 -$21M $1.13M +$129K +12.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$21.1M -$10.6M -$7.17M -207% Oct 1, 2017 Dec 31, 2017 10-K 2018-02-22
Q3 2017 -$13.9M -$6.69M -$7.75M -732% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 -$6.19M -$4.78M -$6.28M -419% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $95K $999K +$84K +9.18% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $11K -$3.46M -$4.39M -473% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-22
Q3 2016 $4.4M $1.06M -$82K -7.19% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-22
Q2 2016 $4.49M $1.5M +$762K +103% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-22
Q1 2016 $3.72M $915K -$354K -27.9% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-22
Q4 2015 $4.08M $929K +$289K +45.2% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-23
Q3 2015 $3.79M $1.14M +$352K +44.6% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-23
Q2 2015 $3.44M $738K +$320K +76.6% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-23
Q1 2015 $3.12M $1.27M +$148K +13.2% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-23
Q4 2014 $2.97M $640K -$1.25M -66.1% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-25
Q3 2014 $4.22M $789K -$1.47M -65% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-25
Q2 2014 $5.68M $418K -$1.08M -72% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-25
Q1 2014 $6.76M $1.12M -$163K -12.7% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-25
Q4 2013 $6.92M $1.89M +$5.02M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-17
Q3 2013 $1.9M $2.26M +$2.27M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-17
Q2 2013 -$372K $1.5M +$1.29M +619% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-17
Q1 2013 -$1.66M $1.28M +$1.23M +2076% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-17
Q4 2012 -$2.88M -$3.14M -$3.15M -19694% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 $267K -$16K Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 $208K Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 $59K Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 $16K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.